2024
Architectural Distortions
Butler R, Durand M, Lanjevar S, Podany P, Andrejeva L, Harigopal M. Architectural Distortions. 2024, 185-207. DOI: 10.1007/978-3-031-65711-5_7.Peer-Reviewed Original ResearchInvasive lobular carcinomaLikelihood of malignancyRadial sclerosing lesionsLobular carcinomaSclerosing lesionsTubular carcinomaArchitectural distortionBenign entityDegree of proliferative changeRadial scar/complex sclerosing lesionDuctal carcinoma in situCarcinoma in situInvasive ductal carcinomaChance of malignancyIncidental microscopic findingAbsence of enhancementPost-contrast imagesMyoepithelial cell layerEntrapped glandsField digital mammographyDiscohesive cellsSonographic correlateDuctal carcinomaInvasive carcinomaPalpable massImplementation of a high-resolution, high-contrast magnetic resonance imaging protocol with extended delayed phases for peritoneal mesothelioma
Medved M, Witmer H, Dhiman A, Berger Y, Sherman S, Hindi E, Armato S, Reiser I, Oto A, Engelmann R, Kindler H, Oren N, Harmath C, Turaga K. Implementation of a high-resolution, high-contrast magnetic resonance imaging protocol with extended delayed phases for peritoneal mesothelioma. Quantitative Imaging In Medicine And Surgery 2024, 14: 2580589-2582589. PMID: 38545076, PMCID: PMC10963817, DOI: 10.21037/qims-23-13.Peer-Reviewed Original ResearchMalignant peritoneal mesotheliomaMagnetic resonance imagingPeritoneal mesotheliomaPost-contrast imagesDelayed phaseDelayed post-contrast imagesT2-weighted single-shot fast spin-echoHigh-contrast magnetic resonance imagingLow grade tumorsLesion contrast enhancementContrast enhancementSingle-shot fast spin-echoGrade of diseaseDose of contrast agentMagnetic resonance imaging examsMagnetic resonance imaging protocolNovel MRI protocolFeasibility of high-resolutionDefinitive surgeryGrade tumorsPeritoneal malignancyBlinded radiologistsTumor gradeAnalysis of contrast enhancementCross-sectional imaging
2022
Synthetic Post-Contrast Imaging through Artificial Intelligence: Clinical Applications of Virtual and Augmented Contrast Media
Pasquini L, Napolitano A, Pignatelli M, Tagliente E, Parrillo C, Nasta F, Romano A, Bozzao A, Di Napoli A. Synthetic Post-Contrast Imaging through Artificial Intelligence: Clinical Applications of Virtual and Augmented Contrast Media. Pharmaceutics 2022, 14: 2378. PMID: 36365197, PMCID: PMC9695136, DOI: 10.3390/pharmaceutics14112378.Peer-Reviewed Original ResearchApplication of artificial intelligencePost-contrast imagesArtificial intelligenceApplications of virtualizationAI computational modelsContrast mediumBiomedical imagingAI applicationsAI modelsRisk of adverse reactionsNon-contrast imagesInput dataIntelligenceAdverse reactionsContrast MediaImagesClinical practiceComputational modelClinical application
2019
Assessment of quantitative methods for enhancement measurement on vessel wall magnetic resonance imaging evaluation of intracranial atherosclerosis
Alexander MD, de Havenon A, Kim SE, Parker DL, McNally JS. Assessment of quantitative methods for enhancement measurement on vessel wall magnetic resonance imaging evaluation of intracranial atherosclerosis. Neuroradiology 2019, 61: 643-650. PMID: 30675639, PMCID: PMC8022353, DOI: 10.1007/s00234-019-02167-3.Peer-Reviewed Original ResearchConceptsIntracranial atherosclerotic diseaseVessel wall magnetic resonance imagingInter-rater agreementLower infundibulumHigh inter-rater agreementVessel wall magnetic resonanceGood inter-rater agreementPost-contrast imagingPresence of enhancementMagnetic resonance imagingPost-contrast imagesRatio of enhancementCulprit lesionIntracranial atherosclerosisAtherosclerotic diseaseInclusion criteriaBlinded reviewersResonance imagingLesion enhancementHigh agreementPlaque signalLesionsInfundibulumObjective dataMagnetic resonance
2009
MR quantification of abnormal stromal enhancement in the periphery of invasive breast tumors
Nabavizadeh N, Klifa C, Newitt D, Lu Y, Hattangadi J, Fisher C, Hylton N, Park C. MR quantification of abnormal stromal enhancement in the periphery of invasive breast tumors. Journal Of Clinical Oncology 2009, 27: 636-636. DOI: 10.1200/jco.2009.27.15_suppl.636.Peer-Reviewed Original ResearchSignal enhancement ratioNormal breast tissueDynamic contrast-enhanced MRIBreast stromaBreast tissueInvasive breast cancer patientsDisease-free survivalBreast cancer patientsHigh tumor vascularityInvasive breast tumorsNormal breast stromaNon-cancerous stromaContrast-enhanced MRIPost-contrast imagesSignal intensity changesTumor-related angiogenesisTumor regionFree survivalCancer patientsPrimary tumorOverall vascularityTumor vascularityAdjusted p-values
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply